Compare HPE & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HPE | GEHC |
|---|---|---|
| Founded | 1939 | 1892 |
| Country | United States | United States |
| Employees | N/A | 54000 |
| Industry | Retail: Computer Software & Peripheral Equipment | Computer Software: Prepackaged Software |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.0B | 32.1B |
| IPO Year | 2015 | 2022 |
| Metric | HPE | GEHC |
|---|---|---|
| Price | $24.57 | $69.43 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 12 |
| Target Price | $26.88 | ★ $89.75 |
| AVG Volume (30 Days) | ★ 16.4M | 3.3M |
| Earning Date | 03-09-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.31% | 0.20% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | 0.31 | ★ 4.55 |
| Revenue | ★ $34,296,000,000.00 | $20,625,000,000.00 |
| Revenue This Year | $20.43 | $7.06 |
| Revenue Next Year | $5.68 | $4.50 |
| P/E Ratio | $79.37 | ★ $15.32 |
| Revenue Growth | ★ 13.84 | 4.84 |
| 52 Week Low | $13.20 | $59.70 |
| 52 Week High | $26.44 | $89.77 |
| Indicator | HPE | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 60.20 | 39.24 |
| Support Level | $23.60 | $69.58 |
| Resistance Level | $24.97 | $74.67 |
| Average True Range (ATR) | 1.16 | 1.76 |
| MACD | 0.17 | 0.28 |
| Stochastic Oscillator | 66.29 | 26.95 |
Hewlett Packard Enterprise is an information technology vendor that provides hardware and software to enterprises. Its primary product lines are compute servers, storage arrays, and networking equipment; it also has a high-performance computing business. HPE's stated goal is to be a complete edge-to-cloud company. Its portfolio enables hybrid clouds and hyperconverged infrastructure.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).